Synthelis Biotech
PrivateLast Round
Grant
Dec 12, 2024
Total Funding Raised
$830,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Synthelis Biotech operates in Healthcare & Life Sciences and is based in La Tronche. Its latest recorded funding round was a Grant round in December 2024.
Synthelis Biotech is a biotechnology company that provides cell-free protein expression systems and bioluminescence solutions for pharmaceutical, biomedical, and academic research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synthelis Biotech Comparables
Compare Synthelis Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LenioBio | 84% | |
| Tierra Biosciences | 83% | |
| CellFree Sciences Co., Ltd. | 83% |
For institutional investors. Book with your work email.
Synthelis Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 12, 2024 | ||||
| M&A | Nov 24, 2023 | ||||
| Seed | Jan 21, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Synthelis Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| France 2030 | Grant |
| Grenoble Angels | Seed |
| Kreaxi | Seed |
| Savoie Mont Blanc Angels | Seed |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 147% MoM, reaching 5.1K.
- Jun 18, 2026
Monthly visitors increased 113% MoM, reaching 2.1K.
For institutional investors. Book with your work email.
Synthelis Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Synthelis Biotech's valuation, stock price, and market status.
Is Synthelis Biotech a public or private company?
Synthelis Biotech is a private company.
What is the current stock price of Synthelis Biotech?
Synthelis Biotech is a private company, so its shares have no public market price. Caplight tracks Synthelis Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synthelis Biotech worth (valuation)?
Valuation information for Synthelis Biotech is not publicly available.
Can I buy Synthelis Biotech stock?
Synthelis Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synthelis Biotech's last funding round?
Synthelis Biotech's most recent funding round was Grant on December 12, 2024.
Who are the main investors in Synthelis Biotech?
Key investors in Synthelis Biotech include France 2030, Grenoble Angels, Kreaxi, Savoie Mont Blanc Angels, Bpifrance.
Will Synthelis Biotech IPO soon?
No public IPO plans have been announced for Synthelis Biotech.
How can I track Synthelis Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Synthelis Biotech's shares on secondary markets.